Embed presentation
Download as PDF, PPTX













































The document discusses the evolution of molecular diagnostics (MDX) emphasizing automation's crucial role in improving methods such as sample preparation, analysis, and data evaluation. It highlights the need for automation driven by demand in clinical labs and details advancements like real-time PCR technologies, nanobiotechnology, and fully automated platforms, which are pivotal for diagnostics in infectious diseases and personalized medicine. Challenges and future directions in MDX, including automation of nucleic acid extraction and the integration of new technologies, are also addressed.











































